INTRODUCTION
Most people with epilepsy live in developing countries 1 and the great majority receive no treatment 2, 3 . Acute intermittent porphyria (AIP) is a rare inherited disease, and seizures are typically a manifestation of acute attacks. AIP may also coexist with idiopathic or symptomatic epilepsy 4 . Since most antiepileptic drugs (AEDs) may precipitate attacks of AIP in susceptible patients, a knowledge of the effects of AEDs is important. Attempts to treat seizures may unmask AIP which has previously remained latent.
CASE REPORT
A 3-year-old boy was seen in the Paediatric Neurology Clinic of the University of Benin Teaching Hospital after having an unprovoked nonfebrile generalized seizure. Patients with a single unprovoked seizure may benefit from treatments with AEDs 5 , and in Nigeria a convulsing young child may be subjected to traditional practices and medications with serious or even fatal results 6, 7 , and so it is considered prudent to attempt to prevent convulsions, whether febrile or nonfebrile, in this age group. Phenobarbitone was prescribed, 45 mg (3 mg kg −1 ) daily.
At the return visit 2 weeks later to assess control of seizures and possible side effects of phenobarbitone, he had remained well, but his mother, who was a nurse, had noticed that his urine became dark after standing. The Watson-Schwarz test for porphobilinogen (PBG) in the urine was strongly positive, and this indicated that latent AIP had been unmasked by phenobarbitone; the drug was gradually withdrawn and carbamazepine 100 mg t.d.s. was commenced.
Four weeks later the Watson-Schwarz test was negative. Carbamazepine was continued for 3 years and gradually withdrawn. The boy remained well with no recurrence of seizures during a further year's follow up, and always came near the top of his class at school. There was no history suggestive of AIP in the mother's family. The father was a surgeon working in another part of the country and was not seen at any time.
DISCUSSION
AIP is the most common of the hepatic porphyrias and results from a deficiency of the enzyme porphobilinogen deaminase. It is inherited as an autosomal dominant, and symptomless and symptomatic heterozygotes have 50% deficiency of the enzyme. Approximately 90% of those who inherit the deficiency remain clinically unaffected throughout their lives. During a crisis the urine may be found to contain PBG, porphyrins and the precursor of PBG, δ-amino-laevulinic acid (ALA) 8 .
AIP is usually latent before puberty and symptoms are more frequent in females than in males. Symptoms may be precipitated by hormonal and nutritional factors, and by the administration of drugs, probably by inducing hepatic ALA-synthase. Amongst the drugs which may do this are most AEDs 8 .
Hereditary coproporphyria is much less common and less severe than AIP, but may cause difficulties in the management of epilepsy in childhood. During a crisis PBG my be found in the urine. In the present case the faeces were not examined for coproporphyrins, so this diagnosis remains a remote possibility 9 .
Abdominal pain is almost always present during a crisis in AIP. Seizures are not infrequent and hypertension and hyponatraemia may be factors. Inappropriate secretion of antidiuretic hormone may be responsible for hyponatraemia.
AIP has been described in West Africa; 1 out of 3 patients who presented with abdominal pain had seizures 10 .
Seizures may be the presenting symptom of AIP in childhood or adult life, in which case the administration of AEDs may have disastrous consequences. A man who was thought to have idiopathic seizures was treated with phenytoin; when his condition worsened treatment was changed to sodium valproate, but deterioration continued. He was found to have AIP; AEDs were discontinued, but recovery from motor neuropathy was incomplete 11 .
Although AIP is usually latent before puberty, 37 cases in children were collected from the literature as long ago as 1974 12 , though not all were fully documented. A child described in that report was initially treated with phenobarbitone and phenytoin. Hypertension and hyponatraemia developed and it was noticed that the urine turned dark red after standing. After the AEDs were withdrawn recovery was complete despite coma for 3 days.
Cases of AIP in childhood have continued to be reported at intervals [13] [14] [15] [16] , though it may be that the use of diazepam, which is safe, rather than phenobarbitone, for the emergency treatment of seizures, has resulted in fewer instances of children with latent AIP developing symptoms of the disease. An alternative and safe emergency treatment of seizures in AIP is magnesium sulphate 17 .
In order to determine the safety of AEDs in AIP, in vitro test systems have been employed. Chick embryo hepatocyte cultures were used, and production of porphyrins was increased by phenobarbitone, phenytoin, sodium valproate, carbamazepine and clonazepam, but not by diazepam or sodium bromide 18 .
Nevertheless, the results of in vitro drug testing do not always apply to all patients. Even drugs thought to be unsafe are not always harmful to patients with AIP 8 , as is shown by the tolerance to carbamazepine of the patient discussed here, and a similar case in a previous report 19 . Clonazepam has also been used safely, at a low dose 20 .
Concerning long-term use of AEDs for children with epilepsy and AIP, textbooks of paediatrics offer little or no advice. Bromides are safe, but are not likely to be tolerated. The modern treatment of choice is probably with gabapentin or vigabatrin 4, 21 , which are not metabolized in the liver. Gabapentin has been used successfully in the treatment of two patients with seizures and AIP 22 .
These newer and safe AEDs are not likely to be available in developing countries, where phenobarbitone is the most widely used drug for epilepsy 23 , largely because of its cheapness. Carbamazepine, though more costly, is available in several countries 23 , and has been found to be effective in intractable epilepsy in children in Nigeria 24 . It is encouraging to know that it may be used, with due consideration and when indicated, in AIP. Monitoring of the urine for PBG is recommended.
